Dr. Modur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
480 Arsenal St
Watertown, MA 02472Phone+1 617-455-2296
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1997 - 2002
- Karnataka Institute of Medical ScienceClass of 1990
Certifications & Licensure
- MO State Medical License 2010 - 2026
- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 8 citationsVenglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase...Ronald T Gansevoort, Ali Hariri, Pascal Minini, Curie Ahn, Arlene B Chapman
American Journal of Kidney Diseases. 2023-05-01 - 2 citationsNovel read through agent: ZKN-0013 demonstrates efficacy in APCmodel of familial adenomatous polyposis.Martin R Graf, Shruti Apte, Esteban Terzo, Simran Padhye, Shuhao Shi
Journal of Molecular Medicine. 2023-04-01 - 15 citationsVenglustat, an orally administered glucosylceramide synthase inhibitor: Assessment over 3 years in adult males with classic Fabry disease in an open-label phase 2 stud...Patrick B Deegan, Ozlem Goker-Alpan, Tarekegn Geberhiwot, Robert J Hopkin, Elena Lukina
Molecular Genetics and Metabolism. 2023-02-01
Press Mentions
- BPGbio Receives FDA Rare Pediatric Disease Designation for Its Investigational Treatment for Epidermolysis BullosaOctober 31st, 2024
- ELX-02 Lowers Sweat Chloride in Patients with G542X Mutation, Trials FindNovember 19th, 2021
- Eloxx Pharmaceuticals Appoints Chief Medical OfficerSeptember 8th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: